Contact
searchSearch
HMP Global
Short Feedback

Advanced Heart Failure and LVAD Strategy: What’s Your Perspective?

10/16/2026

In the 5-statement survey below, share your thoughts on where LVAD therapy fits into a lifetime treatment strategy for patients with advanced heart failure.

 

This content was published with support from Abbott.

Subscriber

Cath Lab Digest Newsletter

Clinical & Industry News

Large-Bore Closure
Haemonetics Announces FDA Approval of PerQseal Elite Vascular Closure System
10/27/2026
The PerQseal Elite system provides sutureless, large-bore vascular closure following structural heart and endovascular procedures performed with 14 – 22F sheaths. Its fully bioabsorbable patch seals arteriotomies up to 26F from within the...
The PerQseal Elite system provides sutureless, large-bore vascular closure following structural heart and endovascular procedures performed with 14 – 22F sheaths. Its fully bioabsorbable patch seals arteriotomies up to 26F from within the...
The PerQseal Elite system...
10/27/2026
Cath Lab Digest
Elucid FFR-IQ
noninvasive physiology
FDA Clears Elucid's FFR-IQ for Noninvasive FFR-CT Assessment
10/21/2026
Elucid's BioIntegrated FFR-CT combines anatomy and biology to noninvasively estimate fractional flow reserve and enable precise treatment of cardiovascular disease.
Elucid's BioIntegrated FFR-CT combines anatomy and biology to noninvasively estimate fractional flow reserve and enable precise treatment of cardiovascular disease.
Elucid's BioIntegrated FFR-CT...
10/21/2026
Cath Lab Digest
Pascal tricuspid (Edwards)
FDA Approval
FDA Approves PASCAL Precision for Transcatheter Tricuspid Valve Repair
10/21/2026
The company also shared that the FDA has approved the PASCAL Ace with Capture Clarity system for use in degenerative mitral TEER procedures (M-TEER).
The company also shared that the FDA has approved the PASCAL Ace with Capture Clarity system for use in degenerative mitral TEER procedures (M-TEER).
The company also shared that the...
10/21/2026
Cath Lab Digest
Shockwave C2 Aero Fly Catheter
Coronary Intravascular Lithotripsy
Johnson & Johnson Launches Next-Generation Shockwave C2 Aero Fly Coronary IVL Catheter, Cutting IVL Treatment Time in Half
10/20/2026
SANTA CLARA, Calif.-- Johnson & Johnson announced the U.S. launch of its Shockwave C2 Aero Fly Coronary IVL Catheter designed to treat a broad range of calcified coronary artery lesions in half the time as previous coronary IVL devices.1...
SANTA CLARA, Calif.-- Johnson & Johnson announced the U.S. launch of its Shockwave C2 Aero Fly Coronary IVL Catheter designed to treat a broad range of calcified coronary artery lesions in half the time as previous coronary IVL devices.1...
SANTA CLARA, Calif.-- Johnson...
10/20/2026
Cath Lab Digest
FDA Approvals
Penumbra's CAVT Technology Receives FDA Clearance for the Treatment of Deep Vein Thrombosis (DVT)
10/20/2026
ALAMEDA, Calif. -- Penumbra, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance for the treatment of deep vein thrombosis (DVT) to the company's Lightning™ computer assisted vacuum thrombectomy (CAVT™)...
ALAMEDA, Calif. -- Penumbra, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance for the treatment of deep vein thrombosis (DVT) to the company's Lightning™ computer assisted vacuum thrombectomy (CAVT™)...
ALAMEDA, Calif. -- Penumbra,...
10/20/2026
Cath Lab Digest
Vertex PE System (Jupiter Endovascular)
Pulmonary Embolism
Jupiter Endovascular Announces Publication of SPIRARE II Pivotal Trial Results Showing Vertex Thrombectomy System Normalized Hemodynamics in 50% of Pulmonary Embolism Patients
10/19/2026
The Vertex system leverages the company’s proprietary Transforming Fixation (TFX) platform technology, a single catheter designed to navigate flexibly through the right heart and stabilize on-demand in the pulmonary arteries for precise,...
The Vertex system leverages the company’s proprietary Transforming Fixation (TFX) platform technology, a single catheter designed to navigate flexibly through the right heart and stabilize on-demand in the pulmonary arteries for precise,...
The Vertex system leverages the...
10/19/2026
Cath Lab Digest
aortic strategy
New Aortic Root Enlargement Technique May Preserve Future TAVI Options After SAVR
10/15/2026
In the spirit of modern ‘lifetime management’, consideration should therefore be given as early as the first procedure to which options remain open for subsequent interventions – such as transcatheter aortic valve implantation (TAVI) within...
In the spirit of modern ‘lifetime management’, consideration should therefore be given as early as the first procedure to which options remain open for subsequent interventions – such as transcatheter aortic valve implantation (TAVI) within...
In the spirit of modern...
10/15/2026
Cath Lab Digest
Cardiology Compensation & Outlook
MedAxiom Releases 2026 Cardiovascular Provider Compensation & Production Survey Report, Revealing Record Compensation, Rising Productivity and Growing Workforce Demands
10/15/2026
National benchmarking report includes data from 205 cardiovascular programs and 6,476 physicians and advanced practice providers.
National benchmarking report includes data from 205 cardiovascular programs and 6,476 physicians and advanced practice providers.
National benchmarking report...
10/15/2026
Cath Lab Digest
ACC Scientific Statement
Exercise Should Be Prescribed as a Core Component of Cardiovascular Care
10/15/2026
The statement emphasizes that the greatest reduction in cardiovascular risk occurs when sedentary individuals become even modestly more active, and the best exercise prescription is one that is safe, individualized, achievable and sustainable...
The statement emphasizes that the greatest reduction in cardiovascular risk occurs when sedentary individuals become even modestly more active, and the best exercise prescription is one that is safe, individualized, achievable and sustainable...
The statement emphasizes that...
10/15/2026
Cath Lab Digest
Renal Denervation
TIME Names Recor Medical’s Paradise Ultrasound Renal Denervation System One of the Best Inventions of 2026
10/15/2026
The Paradise™ Ultrasound Renal Denervation (uRDN) system has been recognized by TIME with a Best Inventions of 2026 award in the Medical and Healthcare category.
The Paradise™ Ultrasound Renal Denervation (uRDN) system has been recognized by TIME with a Best Inventions of 2026 award in the Medical and Healthcare category.
The Paradise™ Ultrasound Renal...
10/15/2026
Cath Lab Digest

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use